RxDoctor Payments Data

Erann Bulman

Gerontology · Knoxville, TNNPI 1841980869

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,904 of the $12,742 with a category attached, or 85.6%. It is spread thinly across 58 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Among gerontology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,742in general payments, 2019–2025

Across 511 payments — averaging $24.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • Lilly USA, LLC$807
  • AstraZeneca$795
  • Johnson & Johnson$600
  • AbbVie$591
  • Pfizer$588
  • plus $7K from 52 others

What the payments were for

  • Food & beverage$10,90486%
  • Education$6425%
  • Other$1,1969%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis59$2,065
Lilly USA, LLC23$807
AstraZeneca(2 entities)30$795
Johnson & Johnson20$600
AbbVie29$591
Pfizer29$588
E.r. Squibb & Sons, L.L.C.23$566
Bristol Myers Squibb33$508
Merck20$499
Genentech USA, Inc.24$482
Regeneron Healthcare Solutions, Inc.15$400
Gilead(2 entities)9$340
Astellas Pharma US Inc14$276
Takeda Pharmaceuticals U.S.A., Inc.11$270
Bayer13$269
Incyte Corporation11$267
GSK12$262
Eisai Inc.12$236
Daiichi Sankyo Inc.9$222
Sanofi9$222
Iovance Biotherapeutics, Inc.2$160
AVEO Pharmaceuticals, Inc.4$157
Karyopharm Therapeutics Inc.5$150
Puma Biotechnology, Inc.9$149
Deciphera Pharmaceuticals Inc.6$148
Genmab U.S., Inc.7$144
Array Biopharma Inc6$130
Exelixis Inc.4$96
Boehringer Ingelheim4$84
Jazz Pharmaceuticals Inc.3$83
Amgen5$76
Beigene USA, Inc.3$75
EMD Serono, Inc.4$74
Sobi, Inc4$74
ADC Therapeutics America, Inc.3$70
Beone Medicines USA, Inc.3$69
Novocure Inc.4$68
Morphosys, US Inc.3$50
Mirati Therapeutics, Inc.2$50
Blueprint Medicines Corporation2$50
Geron Corporation2$49
Taiho Oncology, Inc.2$43
Pharmacosmos Therapeutics Inc.2$41
Rigel Pharmaceuticals, Inc.2$38
Janssen Scientific Affairs, LLC1$35
Caris MPI, Inc.1$33
Myriad Genetic Laboratories, Inc.2$32
Immunogen, Inc.1$29
Syndax Pharmaceuticals, Inc.1$27
Pharmacyclics LLC, An Abbvie Company1$26
Servier Pharmaceuticals LLC1$25
Pharmaessentia USA Corporation1$24
Springworks Therapeutics, Inc.1$24
G1 Therapeutics, Inc.1$22
Tersera Therapeutics LLC1$21
Apellis Pharmaceuticals, Inc.1$20
Verity Pharmaceuticals Inc.1$19
Ipsen Biopharmaceuticals, Inc1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,742 in reported general payments places this provider in the 95th percentile of 194 gerontology providers in Tennessee.

See all gerontology providers in Tennessee

Medicare billing

Part B allowed, 2024
$18,734
Medicare patients
61
Services billed
645

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban30$20,761
Oxycodone Hcl58$1,393
Gabapentin40$788
Tramadol Hcl11$694
Morphine Sulfate ErMorphine Sulfate18$494
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$301
Prochlorperazine Maleate26$292
Ondansetron OdtOndansetron18$225
Lorazepam34$97
Trazodone Hcl16$73
Pantoprazole Sodium11$49
Alprazolam14$46
Warfarin Sodium16$36

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$588$20,76130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 194 gerontology providers in Tennessee.

Other gerontology in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →